Warning: This security is no longer trading.
Cambrex Announces Completion of Acquisition by the Permira Funds
Cambrex Corporation (CBM): Price and Financial Metrics
Cambrex Corporation (CBM)
Today's Latest Price: $59.99 USD
0.00 (0.00%)
Updated Dec 3 6:40pm
Add CBM to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
CBM Stock Summary
- Cambrex Corp's stock had its IPO on September 23, 1987, making it an older stock than 90.93% of US equities in our set.
- CBM's current price/earnings ratio is 54.79, which is higher than 87.37% of US stocks with positive earnings.
- With a year-over-year growth in debt of 62.65%, Cambrex Corp's debt growth rate surpasses 81.95% of about US stocks.
- Stocks that are quantitatively similar to CBM, based on their financial statements, market capitalization, and price volatility, are IOSP, JOUT, ISDR, CC, and MTSC.
- CBM's SEC filings can be seen here. And to visit Cambrex Corp's official web site, go to www.cambrex.com.
CBM Daily Price Range
CBM 52-Week Price Range
CBM Stock Price Chart More Charts
CBM Price/Volume Stats
| Current price | $59.99 | 52-week high | $60.29 |
| Prev. close | $59.99 | 52-week low | $33.80 |
| Day low | $59.98 | Volume | 703,100 |
| Day high | $59.99 | Avg. volume | 425,060 |
| 50-day MA | $59.72 | Dividend yield | N/A |
| 200-day MA | $49.33 | Market Cap | 2.02B |
Cambrex Corporation (CBM) Company Bio
Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. The company was founded in 1981 and is based in East Rutherford, New Jersey.
Top Stories View All
Why Investors Should be Bullish About GW Pharmaceuticals (GWPH)
Why I Believe Facebook (FB) is Headed Higher
Best & Worst Performing Stock Industries for December 10, 2019
Best & Worst Performing Small Cap Stocks for December 10, 2019
Best & Worst Performing Mid Cap Stocks for December 10, 2019
View All Top Stories
Loading social stream, please wait...